Cerenome CNSY
NASDAQ CNSY
$1.68 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:39 AM EDT

Cerenome (CNSY) EBITDA Margin (2011 - 2026)

Updated

Cerenome's EBITDA Margin was -2170.32% in Q2 2026, down 2065.21 percentage points from -105.11% a year earlier and down 1487.15 percentage points from the prior quarter.

Analysis

Cerenome (CNSY) EBITDA Margin (2011 - 2026) Analysis & Trends

On a trailing twelve-month basis, Cerenome's EBITDA Margin was -617.30% through Jun 30, 2026, down 391.55 percentage points year-over-year; for FY2025, it came in at -284.92%, down 47.58 percentage points from FY2024.

  • EBITDA Margin shows a three-year change of +8238.74 percentage points (FY2022 to FY2025).
  • In earlier years, EBITDA Margin was -237.35% in FY2024 (+21.01 pp), -258.36% in FY2023 (+8265.31 pp) and -8523.66% in FY2022.
  • The Q2 2026 figure marks the lowest quarterly EBITDA Margin since Q4 2022.
  • Compared with a year earlier, EBITDA Margin has declined for four straight quarters, with an average year-over-year change of -345.30 percentage points over the last eight quarters.
  • The best year-over-year quarter for EBITDA Margin over five years was Q3 2023 (a gain of 6691.37 percentage points); the worst was Q2 2026 (a drop of 2065.21 percentage points).
  • Per Business Quant data, CNSY's EBITDA Margin in the three quarters before Q2 2026 was -683.17% (Q1 2026), -409.44% (Q4 2025) and -315.32% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 35.95%
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 49.01%
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 6.02%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 33.11%
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 46.01%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -124.26%
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 39.16%
10 Cerenome 11.59 Mn -35.59 Mn - -2,170.32%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,170.32%
Mar 31, 2026 -683.17%
Dec 31, 2025 -409.44%
Sep 30, 2025 -315.32%
Jun 30, 2025 -105.11%
Mar 31, 2025 -320.11%
Dec 31, 2024 -251.56%
Sep 30, 2024 -247.25%
Jun 30, 2024 -275.45%
Mar 31, 2024 -186.52%
Dec 31, 2023 -280.05%
Sep 30, 2023 -69.34%
Jun 30, 2023 -67.21%
Mar 31, 2023 -888.93%
Dec 31, 2022 -3,531.79%
Sep 30, 2022 -6,636.99%
Mar 31, 2019 -221.19%
Dec 31, 2018 -82.70%
Sep 30, 2018 -182.52%
Jun 30, 2018 -191.06%
API Access

Cerenome EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CNSY&period=max&api_key=YOUR_API_KEY